Sun Pharma zooms on signing voluntary licensing agreement with Eli Lilly

10 May 2021 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 698.50, up by 19.00 points or 2.80% from its previous closing of Rs. 679.50 on the BSE.

The scrip opened at Rs. 684.50 and has touched a high and low of Rs. 703.40 and Rs. 683.85 respectively. So far 479311 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 703.40 on 10-May-2021 and a 52 week low of Rs. 434.25 on 18-May-2020.

Last one week high and low of the scrip stood at Rs. 703.40 and Rs. 640.00 respectively. The current market cap of the company is Rs. 167245.64 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.29% and 12.23% respectively.

Sun Pharmaceutical Industries has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (Lilly) for expanding access to Lilly’s drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India.

Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1504.25 -16.30 (-1.07%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.